Purdue Gets OK For $6.5M Investment In Overdose Drug
A New York bankruptcy judge gave Purdue Pharma permission Tuesday to invest $6.5 million in a company working on an over-the-counter opioid-overdose drug, saying that keeping the development effort going was an...To view the full article, register now.
Already a subscriber? Click here to view full article